Royalty Pharma Statistics
NASDAQ: RPRXHealth CareBiotechnology: Pharmaceutical PreparationsUSD
68.45+0.73 (+1.08%)
At close: Nov 20, 4:00 PM ET · Delayed 15 min
Royalty Pharma by the numbers
Royalty Pharma has a market capitalization of $39.36 billion based on 445.27M shares outstanding. Its trailing P/E ratio is 44.7, above the 5-company peer median of 43.2, and its forward P/E is 11.6. The stock trades 9.9% above its 50-day average and 23.9% above its 200-day average.
Average daily trading volume is 3.21M shares, or about $220.0 million in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
RPRX valuation vs. peer median
| Metric | RPRX | Peer median | Difference |
|---|---|---|---|
| Market cap | $39.36B | $31.10B | +27% |
| P/E (TTM) | 44.7 | 43.2 | +3% |
| Forward P/E | 11.6 | 17.4 | -33% |
| Avg. volume | 3.21M | 4.34M | -26% |
Peer median across 8 companies: ONC, ZTS, TEVA, GMAB, INSM, ROIV, UTHR, VTRS.
Valuation
- Market cap
- $39.36B
- P/E (TTM)
- 44.74
- Forward P/E
- 11.62
- Price / sales (latest FY)
- 16.55
- EPS (TTM)
- $1.53
- Shares outstanding
- 445.27M
Price and trading
- Previous close
- 67.72
- Open
- 68.17
- Day range
- 67.95 – 68.83
- 52-week range
- 37.31 – 70.37
- 52-week change
- +75.87%
- Beta
- —
- Volume
- 3.53M
- Average volume
- 3.21M
Dividends and events
- Annual dividend
- $0.925
- Dividend yield
- 1.35%
- Next earnings date
- Nov 4, 2026
Additional statistics
- Market Cap
- 39.36B
- Pe
- 44.74
- Forward Pe
- 11.62
- Eps
- 1.53
- Dividend Yield
- 137.00%
- Dividend Rate
- 0.93
- Week52 High
- 70.37
- Week52 Low
- 37.31
- Avg Volume
- 3.21M
- Shares Outstanding
- 445.27M
- Ma50
- 62.31
- Ma200
- 55.26
- Earnings Date
- Nov 4, 2026
- Pct From52w High
- -2.73%
- Pct From52w Low
- 83.46%